- Posted by dextera
- On June 16, 2016
Consulting VP, Clinical Affairs
Ms. McLaughlin is a veteran medical device professional with more 30 years of experience in both start-up and large commercial organizations. Prior to joining Dextera Surgical, Ms. McLaughlin led the early launch of Abbott Vascular Device’s U.S. drug eluting stent clinical trial and managed the clinical studies leading to CE Marks for a RF catheter for the treatment of a structural heart defect at Cierra and a novel tool for hip arthroscopy at Pivot Medical. Her early career included for more than 10 years with Target Therapeutics as both an employee, and later a consultant, where she helped guide the evolution of the business from an oncology focus to a leader in the field of nascent interventional neuroradiology. Ms. McLaughlin’s extensive consulting experience includes clinical and regulatory leadership as well as publication management, training, marketing and sales force management. She has managed clinical studies and authored regulatory submissions leading to CE Mark, 510(k) and de novo petition clearances for products across a broad spectrum of clinical areas.
Ms. McLaughlin holds a bachelor’s degree in biology from the University of California at Los Angeles as a Regents and Alumni Scholar. Additionally, she serves as a teacher and mentor to students in the Stanford Biodesign program.